@Article{Skrzydło-Radomańska2005,
journal="Przewodnik Lekarza/Guide for GPs",
issn="1505-8409",
year="2005",
title="Current look at effects of long-term proton pump inhibitors therapy",
abstract="Introduction of proton pump inhibitors (PPI) provided an important progress in treatment of the acid-related diseases. PPI are largely administered andand frequently used in long-term therapy. Hypergastrinaemia induced by PPI may lead in human to enterochromaffin-like cells hyperplasia. No neoplastic changes have been reported after more than a decade of use. Fat and mineral bioavailability remain unaltered by PPI therapy. However absorption and profound acid suppression for many years may lead to vitamin B 12  deficiency.",
author="Skrzydło-Radomańska, Barbara",
pages="52--57",
url="https://www.termedia.pl/Current-look-at-effects-of-long-term-proton-pump-inhibitors-therapy,8,4169,1,1.html"
}